LATEST UPDATES » Vol 21, No 12, December 2017 – Skin diseases and allergic reactions       » Gigantic DNA database to be built in Nanjing       » Ineffective baby vaccines by two companies recalled       » Head transplant 'never' to be allowed       » Asia-Pacific, the rising region for cancer vaccine clinical trials       » The hard truth about Eczema      
ASEAN+ Rare Disease Network Established
  • Brings together patient support groups from across Asia to mobilize care and management strategies
  • Participating countries will work together to roll out the Rare Disease Impact Study across the region

SINGAPORE, 22 March 2017 – The first ASEAN+ Rare Disease Network has been established, bringing together patient support groups from across Southeast Asia (Singapore, Malaysia, Indonesia, the Philippines and Vietnam) and Hong Kong. The mission of this Network is to better understand the needs of rare disease patients and their caregivers in the region, in order to identify areas for improvement and mobilize community involvement and humanitarian solutions. Rainbow Across Borders (RAB), a regional patient support group alliance, served as a catalyst towards the establishment of this Network.

The Network will undertake programs to understand the impact of rare diseases in the region as well as plan and coordinate annual rare disease programs for both patients and caregivers. As one of their first initiatives, the Network will work together to roll out the Rare Disease Impact Study across the region. The pilot phase of the study was conducted in Singapore between July to December 2016, and involved 152 patients and caregivers across a wide range of rare diseases particular to the country.

Rajakanth R., Executive Director of RAB said: “The aim of the Impact Study is to better understand the needs of rare disease patients and their caregivers that will ultimately catalyze strategic solutions for the management and care of rare disease patients and their families across the region. Once we collate the data from around the region, we hope to be able to speak as one voice and form a coordinated and collaborative care plan.”

Alison Chang, Project Director of the ASEAN+ Rare Disease Network said: “With all the participant countries coming together to form this Network, the rare disease community is now more unified. These collaborative efforts are vital to rare disease patients and their supporters to drive even greater advocacy efforts.”

The Network comprises Yayasan MPS dan Penyakit Langka Indonesia, Department of Genetics at Hospital Kuala Lumpur, We CARE Journey, Philippines Society for Orphan Disorders, Muscular Dystrophy Association Singapore, Rare Disorders Society Singapore, Hong Kong Alliance for Rare Disorders, Hong Kong Mucopolysaccharidoses & Rare Genetic Diseases Mutual Aid Group and Vietnam Women’s Union. At the kick-off meeting, participants shared their respective country initiatives in conjunction with Rare Disease Day. The Network, which will also be organizing the 3rd Rare Disease Asia Conference that will be held in Bangkok in 2018, hosted their first planning session for the conference. The Network will connect every three months.

Apart from patient support groups, RAB and the ASEAN+ Rare Disease Network also work together with community partners including Shire, a leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions.

About ASEAN+ Rare Disease Network

The ASEAN+ Rare Disease Network comes together as a working team to undertake programs to understand the impact of rare diseases in the region as well as plan and coordinate annual rare disease programs for both patients and caregivers. For more information about the ASEAN+ Rare Disease Network, please contact Rainbow Across Borders at http://www.rabasia.org/contact_us.

About Rainbow Across Borders (RAB)

Rainbow Across Borders (RAB) aims to improve the quality of life of, and give dignity to, patients and families challenged by chronic or life-threatening illnesses. RAB is Asia’s first regional patient support group alliance, which promotes regional collaboration and networking among patient support organizations. RAB aims to empower patient support organizations through appropriate programs, services and training, while facilitating learning and experience exchange among the RAB affiliates.

WorldThroughMyEyes.org.sg is a platform developed by RAB, aimed at energizing and increasing awareness about various chronic illnesses prevalent in Asia, by empowering the voice of patients and caregivers. World Through My Eyes is a collaborative effort that involves numerous patient support organizations and groups from more than 8 countries across Asia. Via this platform, RAB hopes to enhance online advocacy efforts and bring forward the patient voice by sharing patient and caregiver stories on challenges, triumphs, hopes and dreams.

For more information about RAB, log on to http://www.rabasia.org/.

Source: RAB

Click here for the complete issue.

news Separation of conjoined twins presents surgical and ethical challenges for MassGeneral Hospital for Children staff
news MIT Technology Review announces 2018's 10 'Innovators Under 35 Asia'
news Novogen becomes Kazia Therapeutics
Asia Pacific Biotech News

Lady Ganga: Nilza'S Story
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
Healthcare Focus: LUNGS
Get to Know TCM
Diabetes: The Big Picture
The Piece of Your Mind - Brain Health/Science
Advocacies in Support of Rare Disease Patients
Food Science & Technology
Eye – the Window to your Soul
Infectious Diseases
A change of heart — Cardiovascular diseases
Paediatric Illnesses
Skin Diseases and Allergic Reactions
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy